| 发明名称 |
BUPROPION AS A MODULATOR OF DRUG ACTIVITY |
| 摘要 |
Dosage forms, drug delivery systems, and methods related to sustained release of dextromethorphan or improved therapeutic effects are disclosed. Typically, bupropion or a related compound is orally administered to a human being to be treated with, or being treated with, dextromethorphan. |
| 申请公布号 |
US2016375008(A1) |
申请公布日期 |
2016.12.29 |
| 申请号 |
US201615224233 |
申请日期 |
2016.07.29 |
| 申请人 |
ANTECIP BIOVENTURES II LLC |
发明人 |
Tabuteau Herriot |
| 分类号 |
A61K31/485;A61K31/137;A61K9/00 |
主分类号 |
A61K31/485 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of treating depression, comprising: orally administering about 0.3 mg/kg to about 1 mg/kg of a dextromethorphan and about 90 mg to about 140 mg of a bupropion, twice a day for at least 23 days, to a human being suffering from depression. |
| 地址 |
New York NY US |
